Clinical study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in carcinoma of the lung.
D000577:Amides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010919:Placebos
D000577:Amides; D000970:Antineoplastic Agents; D001391:Azo Compounds; D007093:Imidazoles; D009588:Nitrogen Mustard Compounds; D010919:Placebos; D003520:Cyclophosphamide